Pacira BioSciences Inc (NAS:PCRX) Stock News, Headlines & Updates
Pacira BioSciences Inc Stock News from GuruFocus
- 1
- 2
Jul 22, 2025
Pacira BioSciences (PCRX) Partners with J&J to Boost Zilretta Sales
GuruFocus News • 8:55am
Pacira BioSciences Announces Strategic Collaboration to Significantly Expand ZILRETTA Promotional Efforts | PCRX Stock News
GuruFocus News • 7:20am
Pacira BioSciences Inc (PCRX) Announces Strategic Collaboration with Johnson & Johnson MedTech | PCRX stock news
GuruFocus News • 7:01am
Pacira BioSciences Announces Strategic Collaboration to Significantly Expand ZILRETTA Promotional Efforts
Marketwired • 7:00am
Jul 16, 2025
Investors who lost money with shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) should contact the Shareholders Foundation in connection with Lawsuit
PRNewswire • 8:00am
Jul 10, 2025
Pacira BioSciences (PCRX) Announces Layoffs Amid Manufacturing Improvements
GuruFocus News • 7:58am
Jul 03, 2025
Pacira BioSciences Inc (PCRX) Announces Inducement Awards for New Employees | PCRX stock news
GuruFocus News • 4:04pm
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | PCRX Stock News
GuruFocus News • 3:17pm
Jun 18, 2025
Pacira BioSciences Inc (PCRX) Debuts Film Highlighting Non-Opioid Pain Solutions | PCRX stock news
GuruFocus News • 8:04am
Pacira (PCRX) Showcases Film on Non-Opioid Recovery at Biotech Convention | PCRX Stock News
GuruFocus News • 7:30am
Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient's Journey to Pain Relief and Innovation in Care at BIO 2025
Marketwired • 7:00am
Pacira BioSciences Inc (PCRX) Faces Legal Scrutiny Over Patent Validity | PCRX stock news
GuruFocus News • 8:01pm
PACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Pacira BioSciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Marketwired • 8:00pm
Jun 11, 2025
Pacira (PCRX) Shares Promising Long-Term Data for Osteoarthritis Gene Therapy | PCRX Stock News
GuruFocus News • 7:18am
Pacira BioSciences Inc (PCRX) Announces Promising Long-Term Data for Osteoarthritis Gene Therapy | PCRX stock news
GuruFocus News • 7:09am
Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee
Marketwired • 7:00am
Jun 05, 2025
Pacira (PCRX) BioSciences Grants Inducement Awards to New Employees | PCRX Stock News
GuruFocus News • 7:16am
Pacira BioSciences Inc (PCRX) Announces Inducement Awards for New Employees | PCRX stock news
GuruFocus News • 7:01am
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 7:00am
May 15, 2025
Pacira (PCRX) Reports Promising Data on PCRX-201 Gene Therapy for Knee Osteoarthritis | PCRX Stock News
GuruFocus News • 7:48am
Pacira BioSciences Inc (PCRX) Announces Promising Preliminary Data for Gene Therapy Candidate PCRX-201 | PCRX stock news
GuruFocus News • 7:01am
Pacira BioSciences Presents New Data on the Effects of Clinical Immunogenicity on Locally Administered PCRX-201 in Patients with Moderate to Severe Osteoarthritis of the Knee
Marketwired • 7:00am
May 14, 2025
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
Marketwired • 7:00am
May 13, 2025
Lawsuit for Investors in shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) announced by the Shareholders Foundation
PRNewswire • 10:00am
May 09, 2025
Pacira BioSciences (PCRX) Stock Rating Maintained but Price Target Lowered | PCRX Stock News
GuruFocus News • 8:03am
Pacira BioSciences Inc (PCRX) Q1 2025 Earnings Call Highlights: Strong EXPAREL Sales and Strategic Growth Initiatives
GuruFocus News • 1:41am
Decoding Pacira BioSciences Inc (PCRX): A Strategic SWOT Insight
GuruFocus News • 11:41pm
Q1 2025 Pacira Biosciences Inc Earnings Call Transcript
GuruFocus News • 11:21pm
Pacer Advisors, Inc. Significantly Reduces Holdings in Pacira BioSciences Inc
GuruFocus News • 7:57pm
Pacer Advisors, Inc. Reduces Stake in Pacira BioSciences Inc
GuruFocus News • 7:42pm
May 08, 2025
Pacira BioSciences Inc Q1 2025 Earnings: EPS of $0.10 Misses Estimate, Revenue at $168.9 Million Below Forecast
GuruFocus News • 3:44pm
PCRX Reports Lower-Than-Expected Q1 Revenue, Focuses on Long-Term Strategy | PCRX Stock News
GuruFocus News • 3:15pm
Pacira BioSciences Reports First Quarter 2025 Financial Results
Marketwired • 3:00pm
May 07, 2025
Pacira BioSciences Inc (PCRX) Q1 2025: Everything You Need to Know Ahead of Earnings
GuruFocus News • 8:20am
May 06, 2025
Pacira (PCRX) Reveals Promising Phase 1 Study Data for Gene Therapy | PCRX Stock News
GuruFocus News • 7:55am
Pacira BioSciences to Present 3-Year Safety and Efficacy Data of PCRX-201 Following Single Intra-Articular Injection for Moderate-to-Severe Knee Osteoarthritis
Marketwired • 7:00am
May 03, 2025
BlackRock, Inc. Reduces Stake in Pacira BioSciences Inc
GuruFocus News • 3:57am
May 02, 2025
Pacira BioSciences (PCRX) to Present Gene Therapy Study Results | PCRX Stock News
GuruFocus News • 7:46am
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news